Daishi Tian

This is a very early study to see if a new type of cell therapy called GC012F is safe and might help adults with a severe form of inflammatory muscle disease that hasn't responded to other treatments. Doctors will collect a patient's own immune cells, modify them in a lab to pote…

This is a very early study to see if a new type of cell therapy called GC012F is safe and tolerable for people with multiple sclerosis (MS). The therapy involves collecting a patient's own immune cells, modifying them in a lab to potentially target MS, and then infusing them back…

This early-stage study is testing a new, 'off-the-shelf' CAR-T cell therapy called RD06-05 in adults with severe, hard-to-treat neurological autoimmune diseases like multiple sclerosis and myasthenia gravis. The goal is to see if a single infusion of these engineered immune cells…

This is a very early study testing a new type of treatment called GC012F, a CAR-T cell therapy, for people with severe myasthenia gravis that hasn't responded to standard treatments. The main goals are to check if the treatment is safe and to look for early signs that it might he…